U.S. Supreme Court: Federal Trade Commission v. Watson Pharmaceuticals et al [Merck amicus brief]
MLex Summary: Merck has filed a brief with the Supreme Court, urging the justices to reject the U.S. Federal Trade Commission's argument that 'pay for delay' agreements are presumptively unlawful. Merck...To view the full article, register now.
Already a subscriber? Click here to view full article